Patents Assigned to GENOSKIN
  • Patent number: 12158463
    Abstract: Disclosed is an ex vivo model for subcutaneous injection and aims at providing an in vitro method including the steps of i) immersing a skin explant in a solidifiable liquid matrix such that the upper face of the epidermis is not covered, which matrix is itself contained in a cell culture insert, the bottom of which consists of a porous membrane, and (ii) solidifying this matrix so as to trap the immersed portion of this skin explant, wherein the upper face of the epidermis is not covered, and adhering this same matrix to the side walls and the porous membrane of the insert, wherein the skin explant includes a thickness of at least 5 mm of hypodermis.
    Type: Grant
    Filed: March 3, 2019
    Date of Patent: December 3, 2024
    Assignee: GENOSKIN
    Inventors: Pascal Descargues, Emeline Pagès, Claire Jardet
  • Patent number: 12071648
    Abstract: Disclosed is an ex-vivo model of inflamed skin, an in-vitro method for obtaining the same and uses thereof for screening anti-inflammatory compounds. The method includes injecting, into the dermis of a healthy skin biopsy previously taken from a mammal, a composition including an effective amount for activating dermal resident T cells of an anti-CD3 antibody and an anti-CD28 antibody; and b) incubating the injected skin biopsy obtained in step a) in the presence of a composition including an effective amount, for obtaining the polarization of the T cells activated in step a) into LTh1 and/or LTh17 and the synthesis of inflammation markers, of at least one mixture of IL-1?, IL-23, and TGF-?.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: August 27, 2024
    Assignee: GENOSKIN
    Inventors: Claire Jardet, Pascal Descargues, Hanne Norsgaard, Paola Lovato
  • Patent number: 9585381
    Abstract: Disclosed is an in vitro or ex vivo method for preserving and/or keeping alive mammalian, preferably human skin biopsies, enabling to transport it and, if applicable, to culture it. Also disclosed is a skin biopsy thus preserved and obtained by such a method and relates to its use as a model especially in a kit for screening or selecting cosmetic or therapeutic compounds.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: March 7, 2017
    Assignee: GENOSKIN
    Inventor: Pascal Descargues
  • Publication number: 20150132737
    Abstract: Disclosed is an in vitro or ex vivo method for preserving and/or keeping alive mammalian, preferably human skin biopsies, enabling to transport it and, if applicable, to culture it. Also disclosed is a skin biopsy thus preserved and obtained by such a method and relates to its use as a model especially in a kit for screening or selecting cosmetic or therapeutic compounds.
    Type: Application
    Filed: May 3, 2013
    Publication date: May 14, 2015
    Applicant: GENOSKIN
    Inventor: Pascal Descargues